Challenging Cases in Metastatic Pancreatic Cancer: Drs. Midhun Malla & Shafia Rahman
From Oncology Brothers: Practice-Changing Cancer Discussions · · 19 min
This plays from the publisher's own server. We do not host a copy.
Description
Welcome to the Oncology Brothers Podcast! In this episode, we discussed the complexities of pancreatic cancer treatment. Joined by two GI medical oncologists Dr. Midhun Malla, from the University of Alabama and Dr. Shafia Rahman, from the Ohio State University, where they discussed 2 challenging cases that highlighted the nuances of managing metastatic pancreatic adenocarcinoma.
Episode Highlights:
- Case 1: A 63-year-old gentleman with a pancreatic head mass and multiple liver lesions. The discussion focuses on the importance of liquid and solid tissue next-generation sequencing (NGS) testing, treatment options including NALIRIFOX, modified FOLFIRINOX, and gemcitabine plus nab-paclitaxel, and the implications of actionable mutations.
- Case 2: A 71-year-old female with recurrent pancreatic cancer post-Whipple procedure and adjuvant gemcitabine treatment. The experts explore the role of daraxonrasib and the challenges of treatment sequencing after disease progression.
Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o
Follow us on social media:
• X/Twitter: https://x.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Join us as we navigate the latest treatment strategies, the significance of genetic testing, and the balance between efficacy and quality of life in pancreatic cancer care.
#PancreaticCancer, #NGS, #NALIRIFOX, #FOLFIRINOX, #Daraxonrasib, #OncologyBrothers
Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem